Compare NEPH & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEPH | IINN |
|---|---|---|
| Founded | 1997 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0M | 35.3M |
| IPO Year | 2004 | N/A |
| Metric | NEPH | IINN |
|---|---|---|
| Price | $2.88 | $0.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | $2.00 |
| AVG Volume (30 Days) | 46.3K | ★ 123.0K |
| Earning Date | 03-12-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1000.00 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $18,789,000.00 | N/A |
| Revenue This Year | $12.82 | N/A |
| Revenue Next Year | $10.02 | $9,715.95 |
| P/E Ratio | $26.91 | ★ N/A |
| Revenue Growth | ★ 32.67 | N/A |
| 52 Week Low | $1.51 | $0.40 |
| 52 Week High | $6.42 | $1.65 |
| Indicator | NEPH | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 29.42 | 37.26 |
| Support Level | N/A | $0.55 |
| Resistance Level | $4.93 | $0.64 |
| Average True Range (ATR) | 0.24 | 0.03 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 5.24 | 11.11 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.